We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Axxam Provides Screening Assays to NIH Chemical Genomics Centre
News

Axxam Provides Screening Assays to NIH Chemical Genomics Centre

Axxam Provides Screening Assays to NIH Chemical Genomics Centre
News

Axxam Provides Screening Assays to NIH Chemical Genomics Centre

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Axxam Provides Screening Assays to NIH Chemical Genomics Centre "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Axxam has announced that it has signed an agreement with the National Institutes of Health ( NIH)  to provide access to a selection of screening assays of special interest to the NIH Chemical Genomics Centre ( NCGC) for use in the screening campaigns within the Molecular Libraries Roadmap Initiative.

The screening assays were developed and optimized at Axxam for ultra high-throughput screening (uHTS) applications using ultra sensitive signal detection methods.

"We are very pleased to collaborate with the NIH Chemical Genomics Centre in support of their screening efforts," stated Dr. Lia Scarabottolo, head of cell biology at Axxam.

"We believe that our expertise in the uHTS sector, with a particular emphasis on cell-based assays and their use in large screening campaigns, could provide an important contribution to the future success of the Roadmap initiative at the NCGC."
Advertisement